The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Different from type 1 and type 2, type 5 diabetes mostly affects children for genetic reasons. Since it is rare, it often ...

China These authors contributed equally to this work. Correspondence to: Dr. Xi Cao, Beijing Diabetes Institute, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, No.

Taking the drug made one writer feel so sick she quit and focused on healthy habits instead of her body size. Turns out, 65% ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

medullary thyroid cancer and acute kidney injury. Dr Naveed Asif, GP at The London General Practice, advises that patients taking GLP-1 drugs should with a lower dose and gradually titrate up to ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist ...